Results of the trial, which involved more than 32,000 volunteers, showed two doses of the vaccine administered four weeks apart had an efficacy of 79% at preventing symptoms of COVID-19.
Copyright 2021 NPR
AstraZeneca Vaccine Can Prevent COVID-19, Late-Stage Study Says
Facebook Twitter LinkedIn Email